Karen R. Rabin, MD, PhD
- Texas Medical Center
Director, Leukemia Program
|Lucile Packard Children's Hospital||fellowship||Pediatric Hematology Oncology||2004|
|University of California San Francisco||residency||Pediatrics||2001|
|University of California, San Francisco||medical school||Doctor of Medicine||1998|
|Baylor College of Medicine||university|
Dr. Karen Rabin is Director of the Leukemia Program. Her clinical interests include acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Her research interests focus on prognosis, management, and genomics of ALL, with special interests in ALL in children with Down syndrome; and disparities in ALL outcomes in Hispanics.
|American Association of Pediatrics (AAP)||Member|
|American Society of Hematology (ASH)||Member|
|American Society of Pediatric Hematology and Oncology (ASPHO)||Member|
|Children's Oncology Group (COG)||Member|
Dr. Karen Rabin's principal research interest is in ALL in children with Down syndrome, including the molecular basis for development of leukemia in these patients, the basis for their increased risk of treatment-related toxicities, and identification of novel therapeutic targets.
Dr. Rabin also has nationally-recognized expertise in the biology and management of childhood acute lymphoblastic leukemia (ALL). She was Chair of the Children’s Oncology Group (COG) ALL Classification Study AALL08B1; and serves currently as Vice Chair of ALL Biology for COG, and as COG Principal Investigator for Baylor College of Medicine, with responsibility for the oversight of all COG clinical trials conducted at this site.